Prehabilitation in Patients With Cancer and Type 2 Diabetes

May 9, 2023 updated by: Fernando Naclerio, University of Greenwich

Impact of a Multimodal Prehabilitation Programme on Markers of Health, Quality of Life and the Short and Long Post-surgery Recovery Period in Cancer Patients With Type 2 Diabetes

Surgical prehabilitation refers to pre-operative interventions aimed at increasing patients' physiological reserve so that they can better cope with the stress of surgery, avoid post-operative complications and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Although these aspects are well known, having a cancer diagnosis and the likelihood of an incoming operation during the weeks after diagnosis, place patients in a situation where they may be more receptive to adopting lifestyle changes aimed at promoting health. Such changes could be incorporated, not just in the short-term in preparation for surgery, but also in the medium- and long-term, improving patients' wellbeing and potentially reducing the risk of cancer reoccurrence and other diseases.

Although the benefits of prehabilitation before surgery are understood, the effects it may have in non-insulin-dependent Type 2 diabetes patients are unknown.

This project aims to: (i) Analyse the effects of a multimodal prehabilitation programme vs. the current National Health Service (NHS) standard approach, on physical performance in cancer patients with non-insulin-dependent Type 2 diabetes prior to surgery. (ii) Explore the impact of the programme on body composition and metabolic markers. (iii) Analyse the programme adherence, markers of well-being and quality of life during a post-surgery period of up to 12 months as well as its effects on clinical outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This study will take advantage of already existing infrastructures, by approaching a single National Health Service (NHS) hospital in England that is already run a prehabilitation service for its patients. This study will analyse the effect of the prehabilitation programme on a specific group of patients, those with cancer and Type 2 diabetes who do not require insulin as part of their diabetes treatment and who are waiting for surgery.

Surgical prehabilitation refers to interventions done before surgery to increase the patient's overall health and fitness so that they can better cope with the stress of surgery, avoid complications/reduce, and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle, including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation.

Multimodal prehabilitation programmes may use a combination of telehealth and face-to-face delivery to provide flexibility according to the preferences of the patients.

The collaboration between the University of Greenwich and NHS will provide an opportunity to measure the impact of the programme on those participants with Type 2 diabetes, beyond variables like weight and fasting blood glucose (i.e., body composition, glycaemic behaviour, blood insulin concentration, immune system markers…).

The hospital prehabilitation team will identify potential study participants (patients with Type 2 diabetes who do not use insulin awaiting surgery) amongst those referred to their service. The prehabilitation team will present the idea of the study to the potential participants and will ask for consent to share their contact details with the sponsor. If consent is received, the researcher will contact them to briefly present to them the possibility of joining the study. This 1st contact will be overseen by the Chief Investigator.

Those who accept to participate in the study will be allocated into 2 different groups. Patients undergoing prehabilitation will join the prehabilitation group of the study, while those declining prehabilitation will join the control group.

Regardless of the group, all patients will undergo the same number of interactions with the researcher:

  1. Interview and consent The candidate will be provided with the patient information sheet and explained what they can expect and what will be expected from them if they decide to participate in the study. Candidates will be able to ask questions and, in case they decide to participate, they will sign the participant consent form.
  2. Baseline/initial assessment The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.

    This assessment will take place a few weeks before surgery before the patient starts prehabilitation (prehab group) or upon joining the study (control group).

  3. Assessment before surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.

    This assessment will take place a few days before surgery.

  4. Assessment 6 weeks after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.

    This assessment will take place 6 weeks after surgery, a time that generally allows the participant to recover enough to be able to move around comfortably and perform some light physical activity

  5. Assessment 6 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.

    This assessment will take place 6 months after surgery, a time by which the patient will generally be fully recovered, potentially reaching their pre-surgical status, and will have been able to resume their regular day-to-day activity

  6. Assessment 12 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers.

Both groups (prehabilitation and control) will undergo the same previously described assessments. This will allow us to understand and compare how the measured variables change through time in both groups (prehabilitation vs control).

The investigators hypothesise that prehabilitation will improve patients' physical performance prior to surgery and will provide them with a range of tools to help them recover faster and manage their overall health better (including their diabetes control) for at least one year after surgery.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • England
      • Eltham, England, United Kingdom, SE9 2BT
        • School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B)
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Roberto Laza-Cagigas, PhD
        • Sub-Investigator:
          • Ian Swaine, PhD
        • Sub-Investigator:
          • Marcos Seijo, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Capacity to give consent
  • Newly diagnosed with cancer
  • Non-insulin-dependent Type 2 diabetes
  • Awaiting surgery for cancer

Exclusion Criteria:

  • Medical contraindication to engage in physical activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prehabilitation
Arm undergoing multimodal prehabilitation (physical activity, nutritional education and anxiety management) during the weeks leading up to surgery
Participants will be encouraged to engage in regular physical activity (endurance and resistance exercise), eat healthily and undergo cognitive behavioural therapy (the latter only if required) during the weeks prior to surgery.
No Intervention: Standard of care
Arm receiving standard of care (no prehabilitation)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Short Physical Performance Battery (SPPB) at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Group of measures that combines the results of the gait speed, chair stand and balance tests, with scores ranging from 0 (worst performance) to 12 (best performance).
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in fasting glucose at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Blood fasting glucose obtained via finger prick
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Changes in fasting insulin at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Blood fasting insulin obtained via finger prick
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Changes in BMI at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Body mass index
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Changes in waist circumference at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Waist circumference
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Changes in hip circumference at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Hip circumferences
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Changes in Patient Health Questionnaire-9 (PHQ-9) at different time points from baseline to 1 year after surgery
Time Frame: upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Self-administered questionnaires to assess depression severity, with scores ranging from 0 (no depression) to 27 (severe depression)
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital length of stay
Time Frame: 8 weeks after surgery
Number of days spent in the hospital after surgery
8 weeks after surgery
90-day readmission
Time Frame: 90 days after surgery
Number of readmissions during the 90 days after surgery
90 days after surgery
Postsurgical complications
Time Frame: 6 months after surgery
Number of complications after surgery
6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fernando Naclerio, PhD, University of Greenwich

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2023

Primary Completion (Anticipated)

November 30, 2024

Study Completion (Anticipated)

April 30, 2025

Study Registration Dates

First Submitted

September 12, 2022

First Submitted That Met QC Criteria

September 15, 2022

First Posted (Actual)

September 21, 2022

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Multimodal surgical prehabilitation

3
Subscribe